AIM’s Latest Newsletter: The Research Edition, July 2023
Published:
08/01/2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.
This edition features:
- Letter from AIM’s President, Sam Guild
- Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory - In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO - Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
By Alicia Rowell, Vice President, AIM at Melanoma
Recent Posts

May. 14, 2025
Parenting Through Cancer

May. 09, 2025
Tri-State Melanoma Consortium – Inaugural Convening

May. 01, 2025
AIM at Melanoma + WEARSPF®: Partnering for a Cause This Melanoma Awareness Month

May. 01, 2025
Hope, Purpose, and Progress: Melanoma Awareness Month with AIM

Apr. 28, 2025